Biocon biosimilar business valued at $3bn in funding round
Biocon Biologics receives True North investment that values biosimilar business at around $3bn.
Archives for January 14, 2020
Yposkesi doubles manufacturing footprint to meet AAVs growing demand
Yposkesi CDMO announces expansion to cover growing demand, strikes a deal on viral vectors production for a gene therapy development project.
FDA places Innate cancer trial on partial clinical hold over CMO issue
The US FDA puts Innate Pharma trial on partial clinical hold after learning of CMO problems.